Pallas vs Shed: GLP-1 Telehealth Compared

Shed (tryshed.com, formerly ShedRx) is one of the bigger names in compounded GLP-1 telehealth, known for its money-back guarantee and a broad medication menu that runs from weekly injections to lozenges and drops. Pallas Health is a GLP-1-focused platform built around a different idea: one flat, all-in price and terms you can leave anytime. Both are worth considering — this comparison is about which structure fits how you want to buy healthcare.

This is an honest comparison. Pricing on both sides changes often; figures reflect each platform's published pricing and terms as of August 2026 — confirm current numbers on both sites before signing up.

The three differences that matter most

1. The guarantee versus the exit terms. Shed's headline is a 120-day money-back guarantee: lose at least 5% of your baseline weight in 120 days or get that period's payments back. It's real — and conditional. Per Shed's own terms you must attend all four monthly coaching appointments, log at least two weight entries per month, complete at least half of the daily check-ins, submit every provider follow-up form on time, and be a first-time user of the medication class. Pallas offers no weight-loss guarantee — instead, the terms are simple in the other direction: full refund if a clinician decides treatment isn't right for you, and cancel anytime.
2. The commitment. Shed's programs require a minimum two-month commitment; early cancellation doesn't release you from payment, cancellation requires 72 hours' notice before billing, and fees are non-refundable once charged, per its published terms. Pallas has no minimum term, no notice window, and self-serve cancellation in the portal.
3. The price shape. Shed advertises compounded semaglutide "as low as $159/month" alongside standard "starting at $249/month" rates (tirzepatide: $239 featured, $349 starting). Pallas is one all-in number stated with its renewal up front: $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. Compounded tirzepatide injection is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. Whichever platform you choose, get the ongoing rate — not the featured rate — in writing before you enroll.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Quick comparison

What Shed does well

A real guarantee — if you'll do the program. No other major GLP-1 platform puts a weight-loss outcome guarantee in its terms. If you want built-in accountability — monthly coaching appointments, daily check-ins, tracked weigh-ins — Shed's structure rewards exactly that, and the 5%-in-120-days bar is one most engaged GLP-1 patients clear. Read the commitments first; missing one voids the claim.

Menu breadth. Shed offers compounded GLP-1s in more formats than almost anyone — weekly injections, lozenges, liquid drops, and oral tablets — plus a wide non-GLP-1 catalog. If a clinician judges a non-injection format appropriate for you, Shed has options Pallas doesn't.

Scale. Shed reports over 150,000 members, operates async-first ("no appointment required" in most states), and displays a LegitScript seal on its site.

What Pallas does differently

No commitments, no conditions. Pallas's bet is that simple terms beat conditional ones: one all-in price — $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. — with the provider, dose adjustments, unlimited messaging, and shipping included, a full refund if a clinician doesn't prescribe, and cancellation that's yours to click at any time. No two-month minimum, no notice window, no guarantee paperwork.

The lower stated entry and average. Pallas's first month for compounded semaglutide is below Shed's featured entry price, and the ongoing per-month average sits below Shed's standard starting rate — with the renewal amount printed next to the intro price on every Pallas surface, so there's no ambiguity about what month four costs.

Brand-name access, dispensed. Both platforms list FDA-approved brands, but per Shed's terms its members purchase brand medications directly through LillyDirect or NovoCare. Pallas dispenses Wegovy®, Ozempic®, Zepbound®, and Mounjaro® cash-pay through its US-licensed pharmacy network — one platform, one checkout, whichever tier your clinician recommends.

Medication-first, not program-first. Pallas doesn't attach coaching requirements to anything. Care is asynchronous in most states, your provider is a portal message away day or night, and the free Pallas companion app (iOS and Android) covers protein, steps, weight trend, and dose reminders — as a tool, not an obligation.

Who should pick which

Shed is probably the better fit if:

• You want an outcome guarantee and you'll genuinely complete the coaching visits, check-ins, and logs it requires
• You want a non-injection compounded format (lozenge, drops, oral tablet) and a clinician judges it appropriate
• You like structured accountability built into the program

Pallas is probably the better fit if:

• You want the lowest-friction terms: no minimum commitment, no cancellation notice window, full refund if not prescribed
• You want one all-in price with the renewal stated up front, flat at every dose
• You want brand-name medications dispensed through the same platform rather than purchased separately
• You prefer medication-first care with optional tracking, not required program activities

Switching between them

Bring your medication name, current dose, and titration history (export or screenshot your records first). Mind Shed's terms when timing a switch — the two-month minimum and 72-hour billing notice determine your last paid cycle. A Pallas clinician picks up from your current dose; no restart of titration unless you've been off medication for more than four weeks. For the clinical side of choosing between molecules, see semaglutide vs tirzepatide.

References

Platform pricing and program details reflect each company's publicly published terms as of August 2026 and change frequently — confirm current numbers on each platform's site before enrolling. The regulatory basis for compounded preparations is summarized by the FDA.

1. Shed. Weight-loss pricing and terms and conditions (120-day guarantee conditions, two-month minimum, cancellation policy), as published August 2026.
2. U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. 2025.

Bottom line: Shed sells a program — coaching, check-ins, a broad medication menu, and a real 120-day guarantee whose conditions you should read twice. Pallas sells the simplest possible structure: one all-in price with the renewal printed beside it, no minimum commitment, a full refund if a clinician doesn't prescribe, cancel anytime, and both medication tiers dispensed in one place. If accountability structure helps you, Shed's model is genuinely built for it; if you want clean terms and a flat number, that's exactly what Pallas is.